120 related articles for article (PubMed ID: 9532409)
1. The blood-brain barrier disruption controversy: does it hold water?
Ruffer JE; Glatstein E
Cancer J Sci Am; 1998; 4(2):84-5. PubMed ID: 9532409
[No Abstract] [Full Text] [Related]
2. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
3. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM
J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
[TBL] [Abstract][Full Text] [Related]
4. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].
Heimberger K; Samec P; Podreka I; Binder H; Suess E; Reisner T; Deecke L; Steger G; Hiesmayr M; Dittrich C
Wien Klin Wochenschr; 1987 May; 99(11):385-8. PubMed ID: 3113082
[TBL] [Abstract][Full Text] [Related]
5. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Goldstein DA; Tessler HH
Am J Ophthalmol; 2007 Dec; 144(6):976; author reply 976. PubMed ID: 18036877
[No Abstract] [Full Text] [Related]
6. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
Kemper EM; Boogerd W; Thuis I; Beijnen JH; van Tellingen O
Cancer Treat Rev; 2004 Aug; 30(5):415-23. PubMed ID: 15245774
[TBL] [Abstract][Full Text] [Related]
7. [Temporary hyperosmolar breakage of the blood-brain barrier improves effectiveness of chemotherapy for cerebral tumors].
Aronov MS; Kobiakov GL; Lubnin AIu; Iakovlev SB
Zh Vopr Neirokhir Im N N Burdenko; 2008; (3):52-9. PubMed ID: 19062597
[No Abstract] [Full Text] [Related]
8. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW
Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316
[TBL] [Abstract][Full Text] [Related]
9. Blood-tumor barrier disruption controversies.
Blasberg RG; Groothuis DR
J Cereb Blood Flow Metab; 1991 Jan; 11(1):165-8. PubMed ID: 1898507
[No Abstract] [Full Text] [Related]
10. Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Galor A; Ference SJ; Singh AD; Lee MS; Stevens GH; Perez VL; Peereboom DM
Am J Ophthalmol; 2007 Jul; 144(1):45-49. PubMed ID: 17601426
[TBL] [Abstract][Full Text] [Related]
11. Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent delivery.
Neuwelt EA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Hill SA; Lewis SE; Ehle AL; Beyer CW; Moore RJ
Trans Am Neurol Assoc; 1979; 104():256-60. PubMed ID: 121949
[No Abstract] [Full Text] [Related]
12. An appraisal of chemotherapy: in the blood or in the brain?
Schmidt MH; Chang SM; Berger MS
Clin Neurosurg; 2001; 48():46-59. PubMed ID: 11692656
[No Abstract] [Full Text] [Related]
13. [Pharmacodynamics and pharmacokinetics of therapeutic osmoregulating agents in increased intracranial pressure].
Prange HW; Nau R
Zentralbl Neurochir; 1997; 58(3):127-33. PubMed ID: 9446463
[No Abstract] [Full Text] [Related]
14. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).
van Vulpen M; Kal HB; Taphoorn MJ; El-Sharouni SY
Oncol Rep; 2002; 9(4):683-8. PubMed ID: 12066192
[TBL] [Abstract][Full Text] [Related]
15. Mannitol and cardiac surgery.
Poullis M
Thorac Cardiovasc Surg; 1999 Feb; 47(1):58-62. PubMed ID: 10218625
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain-barrier disruption interventional neuroradiology in brain tumor therapy.
Heimberger K; Samec P; Binder H; Horaczek A; Mutz N
Ann Radiol (Paris); 1986; 29(2):230-2. PubMed ID: 3090924
[No Abstract] [Full Text] [Related]
17. [Hemodynamic effects of an osmotic bolus for the reversible opening of the blood-brain barrier].
Hiesmayr M; Dirnberger H; Aloy A; Heimberger K; Horaczek A; Brandstätter B; Zimpfer M
Schweiz Med Wochenschr; 1987 Mar; 117(12):450-4. PubMed ID: 3107120
[TBL] [Abstract][Full Text] [Related]
18. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
[TBL] [Abstract][Full Text] [Related]
19. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
Blanchette M; Pellerin M; Tremblay L; Lepage M; Fortin D
Neurosurgery; 2009 Aug; 65(2):344-50; discussion 350-1. PubMed ID: 19625914
[TBL] [Abstract][Full Text] [Related]
20. Ocular complication of combined intracarotid chemotherapy and osmotic blood-brain barrier disruption.
Suda K; Nakasu S; Saito A
Nihon Geka Hokan; 1985 Sep; 54(5):359-63. PubMed ID: 3938210
[No Abstract] [Full Text] [Related]
[Next] [New Search]